Literature DB >> 15351053

Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.

G W Xu1, Q H Yao, Q F Weng, B L Su, X Zhang, J H Xiong.   

Abstract

Increased oxidative stress induced by hyperglycemia may contribute to the pathogenesis of diabetic complications. Urinary 8-hydroxydeoxyguanosine (8-OHdG) has been reported to serve as a sensitive biomarker of oxidative DNA damage and also of oxidative stress. This article studied oxidative DNA damage in patients with diabetic nephropathy and in healthy control subjects by urinary 8-OHdG evaluations. Contents of 8-OHdG in urine were analyzed by capillary electrophoresis with end-column amperometric detection (CE-AD) after a single-step solid-phase extraction (SPE). Levels of urinary 8-OHdG in diabetic nephropathy patients with macroalbuminuria was significant higher than in control subjects (5.72 +/- 6.89 micromol/mol creatinine versus 2.33 +/- 2.83 micromol/mol creatinine, P = 0.018). A significant difference of 24 h urinary 8-OHdG excretions exists between the patients with macroalbuminuria and the patients with normoalbuminuria (19.2 +/- 16.8 microg/24 h versus 8.1 +/- 1.7 microg/24 h, P = 0.015). There was a positive correlation between urinary excretion of 8-OHdG and glycosylated hemoglobin (HbA1c) (r = 0.287, P = 0.022). A weak correlation exists between the levels of 8-OHdG and triglyceride (r = 0.230, P = 0.074). However, the urinary 8-OHdG contents are not correlated with blood pressure and total cholesterol. The increased excretion of urinary 8-OHdG is seen as indicating an increased systemic level of oxidative DNA damage in diabetic nephropathy patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351053     DOI: 10.1016/j.jpba.2004.04.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  22 in total

1.  Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Authors:  Manuel Sanchez; Ronan Roussel; Samy Hadjadj; Abdul Moutairou; Michel Marre; Gilberto Velho; Kamel Mohammedi
Journal:  Diabetologia       Date:  2017-11-28       Impact factor: 10.122

2.  Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats.

Authors:  Joana Noguères Simas; Talita Biude Mendes; Camila Cicconi Paccola; Vanessa Vendramini; Sandra Maria Miraglia
Journal:  Int J Exp Pathol       Date:  2017-12-29       Impact factor: 1.925

3.  Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.

Authors:  Su-Tze Chou; Shih-Ting Tseng
Journal:  Clin Exp Nephrol       Date:  2016-05-27       Impact factor: 2.801

4.  Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation.

Authors:  Fenping Zheng; Weina Lu; Chengfang Jia; Hong Li; Zhou Wang; Weiping Jia
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

Review 5.  Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Authors:  Runa Lindblom; Gavin Higgins; Melinda Coughlan; Judy B de Haan
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 6.  Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.

Authors:  N Ohashi; M Urushihara; H Kobori
Journal:  Minerva Urol Nefrol       Date:  2009-03       Impact factor: 3.720

Review 7.  Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress.

Authors:  Hasna Tirichen; Hasnaa Yaigoub; Weiwei Xu; Changxin Wu; Rongshan Li; Yafeng Li
Journal:  Front Physiol       Date:  2021-04-23       Impact factor: 4.566

8.  Evaluation of chromosomal instability in diabetic rats treated with naringin.

Authors:  Saleh A Bakheet; Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2011-09-20       Impact factor: 6.543

9.  Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy.

Authors:  Kasper Broedbaek; Trine Henriksen; Allan Weimann; Morten Petersen; Jon T Andersen; Shoaib Afzal; Espen Jimenez-Solem; Frederik Persson; Hans-Henrik Parving; Peter Rossing; Henrik E Poulsen
Journal:  Diabetes Care       Date:  2011-03-31       Impact factor: 19.112

10.  Effects of curcumin on retinal oxidative stress and inflammation in diabetes.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Nutr Metab (Lond)       Date:  2007-04-16       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.